Editas Medicine
EDIT
#7746
Rank
โ‚ฌ0.37 B
Marketcap
2,44ย โ‚ฌ
Share price
-3.81%
Change (1 day)
-14.63%
Change (1 year)

Revenue for Editas Medicine (EDIT)

Revenue in 2026 (TTM): โ‚ฌ32.96 Million

According to Editas Medicine 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ33.9 Million. In 2025 the company made a revenue of โ‚ฌ34.49 Million an increase over the revenue in the year 2024 that were of โ‚ฌ31.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Editas Medicine from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ32.96 M-4.42%
2025 โ‚ฌ34.49 M11.08%
2024 โ‚ฌ31.05 M-56.06%
2023 โ‚ฌ70.67 M284.59%
2022 โ‚ฌ18.37 M-18.53%
2021 โ‚ฌ22.55 M-69.42%
2020 โ‚ฌ73.76 M302.49%
2019 โ‚ฌ18.32 M-34.35%
2018 โ‚ฌ27.91 M144%
2017 โ‚ฌ11.44 M98.82%
2016 โ‚ฌ5.75 M286.25%
2015 โ‚ฌ1.48 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
โ‚ฌ0.12 M-99.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚ฌ19.13 M-43.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚ฌ0.52 B 1,441.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
โ‚ฌ0.59 B 1,642.99% Jersey